Elevation Point Wealth Partners LLC purchased a new position in BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 35,850 shares of the company’s stock, valued at approximately $571,000.
A number of other large investors have also modified their holdings of BCAT. Geneos Wealth Management Inc. increased its stake in shares of BlackRock Capital Allocation Term Trust by 341.7% during the second quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after buying an additional 1,582 shares during the period. McIlrath & Eck LLC lifted its stake in BlackRock Capital Allocation Term Trust by 169.6% in the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock worth $44,000 after acquiring an additional 1,969 shares during the last quarter. Parallel Advisors LLC acquired a new position in BlackRock Capital Allocation Term Trust during the 3rd quarter worth approximately $47,000. Brown Brothers Harriman & Co. increased its position in shares of BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after purchasing an additional 4,500 shares during the last quarter. Finally, Global Retirement Partners LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter valued at $115,000. Hedge funds and other institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Stock Down 0.8%
BlackRock Capital Allocation Term Trust stock opened at $15.77 on Tuesday. The company has a fifty day simple moving average of $15.80 and a 200-day simple moving average of $15.32. BlackRock Capital Allocation Term Trust has a 12-month low of $13.73 and a 12-month high of $16.20.
BlackRock Capital Allocation Term Trust Announces Dividend
BlackRock Capital Allocation Term Trust Company Profile
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
See Also
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
